Features of Preclinical Studies of Cell Therapy Products
Preclinical studies are one of the most important stages in the development of drugs for medical use, including cell therapy products (in accordance with the legislation of the Russian Federation — biomedical cell products). Regulatory authorities decide on the possibility of conducting clinical tri...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-12-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849693095780679680 |
|---|---|
| author | E. V. Melnikova M. D. Khorolsky O. A. Rachinskaya V. A. Merkulov |
| author_facet | E. V. Melnikova M. D. Khorolsky O. A. Rachinskaya V. A. Merkulov |
| author_sort | E. V. Melnikova |
| collection | DOAJ |
| description | Preclinical studies are one of the most important stages in the development of drugs for medical use, including cell therapy products (in accordance with the legislation of the Russian Federation — biomedical cell products). Regulatory authorities decide on the possibility of conducting clinical trials in order to bring the medications to the market on the basis of the results of the study of their specific activity and safety. Russian requirements for preclinical studies of cell therapy products generally correspond to foreign ones, the main difference is the need for an expanded program of their conduct. The article analyzes the aspects of preclinical studies (scope, justification of the reduced program, design, animal models used) of some cell therapy products approved for use in medical practice in the United States, the European Union, Japan, and South Korea. |
| format | Article |
| id | doaj-art-47a33dcddb6b45e39a82c3e1fb3f72b1 |
| institution | DOAJ |
| issn | 0235-2990 |
| language | Russian |
| publishDate | 2020-12-01 |
| publisher | LLC "Publishing House OKI" |
| record_format | Article |
| series | Антибиотики и Химиотерапия |
| spelling | doaj-art-47a33dcddb6b45e39a82c3e1fb3f72b12025-08-20T03:20:32ZrusLLC "Publishing House OKI"Антибиотики и Химиотерапия0235-29902020-12-01659-10516310.37489/0235-2990-2020-65-9-10-51-63751Features of Preclinical Studies of Cell Therapy ProductsE. V. Melnikova0M. D. Khorolsky1O. A. Rachinskaya2V. A. Merkulov3Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian FederationScientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian FederationScientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian FederationScientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian FederationPreclinical studies are one of the most important stages in the development of drugs for medical use, including cell therapy products (in accordance with the legislation of the Russian Federation — biomedical cell products). Regulatory authorities decide on the possibility of conducting clinical trials in order to bring the medications to the market on the basis of the results of the study of their specific activity and safety. Russian requirements for preclinical studies of cell therapy products generally correspond to foreign ones, the main difference is the need for an expanded program of their conduct. The article analyzes the aspects of preclinical studies (scope, justification of the reduced program, design, animal models used) of some cell therapy products approved for use in medical practice in the United States, the European Union, Japan, and South Korea.https://www.antibiotics-chemotherapy.ru/jour/article/view/766cell therapybiomedical cell productpreclinical studiespharmacological studiesbiodistributiontoxicity studiestumorogenicity |
| spellingShingle | E. V. Melnikova M. D. Khorolsky O. A. Rachinskaya V. A. Merkulov Features of Preclinical Studies of Cell Therapy Products Антибиотики и Химиотерапия cell therapy biomedical cell product preclinical studies pharmacological studies biodistribution toxicity studies tumorogenicity |
| title | Features of Preclinical Studies of Cell Therapy Products |
| title_full | Features of Preclinical Studies of Cell Therapy Products |
| title_fullStr | Features of Preclinical Studies of Cell Therapy Products |
| title_full_unstemmed | Features of Preclinical Studies of Cell Therapy Products |
| title_short | Features of Preclinical Studies of Cell Therapy Products |
| title_sort | features of preclinical studies of cell therapy products |
| topic | cell therapy biomedical cell product preclinical studies pharmacological studies biodistribution toxicity studies tumorogenicity |
| url | https://www.antibiotics-chemotherapy.ru/jour/article/view/766 |
| work_keys_str_mv | AT evmelnikova featuresofpreclinicalstudiesofcelltherapyproducts AT mdkhorolsky featuresofpreclinicalstudiesofcelltherapyproducts AT oarachinskaya featuresofpreclinicalstudiesofcelltherapyproducts AT vamerkulov featuresofpreclinicalstudiesofcelltherapyproducts |